Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials
Opinion
Video
Sarah Rockwell, PharmD, BCOP, provides an overview of the safety and efficacy data of bispecific antibodies investigated in the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 trials, providing critical insights into the results of each study.